Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0063
0.00 (0.00%)
At close: Oct 20, 2026
Evofem Biosciences Revenue
Evofem Biosciences had revenue of $2.63M in the quarter ending June 30, 2026, a decrease of -45.43%. This brings the company's total for the last twelve months to $18.05M, up 4.49% year-over-year. In the year 2025, Evofem Biosciences had annual revenue of $20.18M with 4.23% growth. That makes Evofem Biosciences the 34,380th largest company in the world by revenue and 4,527th in the United States.
Revenue (ttm)
18.05M
Revenue Growth
+4.49%
P/S Ratio
0.05
Revenue / Employee
622.24K
Employees
29
Market Cap
834.94K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.18M | 820.00K | 4.23% |
| Dec 31, 2024 | 19.36M | 1.15M | 6.28% |
| Dec 31, 2023 | 18.22M | 1.38M | 8.20% |
| Dec 31, 2022 | 16.84M | 8.59M | 104.23% |
| Dec 31, 2021 | 8.24M | 7.80M | 1,748.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SQZ Biotechnologies Company | 12.12M |
| Regenerative Medical Technology Group | 9.41M |
| Helix BioMedix | 2.07M |
| Avenue Therapeutics | 1.40M |
| AXIM Biotechnologies | 92.90K |
| Aditxt | 14.34K |
| Halberd | 6.94K |
Evofem Biosciences News
- 27 days ago - Evofem Biosciences Adds Additional Manufacturing Capacity for PHEXX® to Support Global Growth Strategy - Business Wire
- 2 months ago - Evofem Biosciences Quarterly report: Q2 2026 - Filings
- 2 months ago - Evofem Biosciences Earnings release: Q2 2026 - Filings
- 2 months ago - Evofem reports shipment of 500,000th box of PHEXX - TheFly
- 3 months ago - Evofem Biosciences Slides: Investor presentation - Filings
- 5 months ago - Evofem reports Q1 EPS (4c) vs. 0c last year - TheFly
- 5 months ago - Evofem Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 5 months ago - Evofem Biosciences Quarterly report: Q1 2026 - Filings